Petros Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Petros Pharmaceuticals, Inc. (PTPI) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $25.78 thousand as of 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2025-03-31
- 2024-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $25.78K.
- 2023-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $56.00K.
- 2023-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $66.22K.
- 2023-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $77.49K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2024-12-31 | $25.78K 10-K · filed 2025-03-31 |
| 2023-12-31 | $56.00K 10-K · filed 2024-04-01 |
| 2023-09-30 | $66.22K 10-Q · filed 2023-11-15 |
| 2023-06-30 | $77.49K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $89.77K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $103.03K 10-K · filed 2023-03-31 |
| 2022-09-30 | $117.23K 10-Q/A · filed 2022-11-15 |
| 2022-06-30 | $132.35K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $148.34K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $165.19K 10-K · filed 2022-03-31 |
| 2021-09-30 | $182.86K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $201.32K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $220.52K 10-Q · filed 2021-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |